A paved hike- and bike-only path in central Minnesota that skirts a dozen lakes. Built on built on an abandoned Burlington ...

Bristol Myers Squibb's Breyanzi showed strong efficacy in Phase 2 lymphoma trial, meeting key endpoints. FDA approvals expand its reach in B-cell cancers.

Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC. Amezalpat builds ...

New blinded preliminary BRTX-100 data described this past Saturday at prestigious “2025 Winners in Industry Innovations in MSK Health” ...

The global Smart Water Meters Market is anticipated to grow from estimated USD 4.61 billion in 2024 to USD 9.04 billion by 2030, at a CAGR ...

LOS ANGELES -- In the PRESTIGE-AF trial, survivors of intracerebral hemorrhage (ICH) had good protection against future ischemic events using direct oral anticoagulants (DOACs) -- though, as feared, ...

Leave it to a Canadian to have the proverbial ice water in his veins at a time of year when his fellow Canucks are actively avoiding the real thing at home. With a birdie-4 in the second hole of a ...

Patients with BRAF V600E-mutated metastatic colorectal cancer experienced improved responses when treated with Braftovi plus Erbitux and mFOLFOX6.

The Massachusetts Bay Transportation Authority will launch South Coast Rail operations — serving a group of southeastern ...

Financial writer discusses Coya Therapeutics, Inc.'s Treg therapies for neurodegenerative diseases like ALS, FTD, and PD.

Insmed Incorporated INSM announced that the FDA has accepted its new drug application (“NDA”) seeking approval of its ...

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...